tracken
Aktienkurs
229,47
$
+26,53
13,07 %1 M.
+4,34
1,93 %6 M.
+24,58
12,00 %YTD
-2,53
1,09 %1 J.
+72,31
46,01 %3 J.
+123,89
117,34 %5 J.
+187,36
444,93 %10 J.
NYSE,
Schlusskurs Fr, 27.01.2023
Powered by
ISIN
US46266C1053
Symbol
IQV
Index
Sektor
Industrie
Kennzahlen
| Marktkapitalisierung | 42,62 Mrd. USD |
| Enterprise Value | 53,91 Mrd. USD |
| KGV (TTM) KGV | 37,33 |
| EV/FCF (TTM) EV/FCF | 31,62 |
| EV/Sales (TTM) EV/Sales | 3,77 |
| KUV (TTM) KUV | 2,98 |
| KBV (TTM) KBV | 7,97 |
| Umsatzwachstum (TTM) Umsatzwachstum | 5,84 % |
| Umsatz (TTM) Umsatz | 14,31 Mrd. USD |
Mehr anzeigen
Ist IQVIA eine Topscorer-Aktie nach der Dividenden-, High-Growth-Investing- oder Levermann-Strategie?
Als kostenloser aktien.guide Basis-Nutzer kannst Du die Scores zu allen 6.905 weltweiten Aktien einsehen.
Finanzdaten von IQVIA
| Sep. '22 |
+/-
%
|
||
| Umsatz | 14.311 14.311 |
6 %
6 %
|
|
| Bruttoertrag | 3.937 3.937 |
26 %
26 %
|
|
| EBITDA | 2.942 2.942 |
15 %
15 %
|
EBIT (Operatives Ergebnis) EBIT | 1.907 1.907 |
56 %
56 %
|
| Nettogewinn | 1.182 1.182 |
54 %
54 %
|
|
Angaben in Millionen USD.
Nichts mehr verpassen! Wir senden Dir alle News zur IQVIA-Aktie direkt und kostenlos in Deine Mailbox.
Auf Wunsch erhältst Du jeden Morgen pünktlich zum Frühstück eine E-Mail, die alle für Dich relevanten Aktien-News enthält.
IQVIA Aktie News
Seeking Alpha
2 Tage alt
|
Positiv
IQVIA: A Clear Case Of Why High ROIC Justifies High P/E Rating
IQVIA continues to demonstrate its propensity to generate growth and future value for shareholders. Here, we peel back the layers to demonstrate the underlying economics in the company's business model.
IQVIA continues to demonstrate its propensity to generate growth and future value for shareholders. Here, we peel back the layers to demonstrate the underlying economics in the company's business model.
Seeking Alpha
4 Tage alt
|
Positiv
IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader
IQVIA is one of my favorite investments thanks to it being one of the leading CROs with a broad array of services. IQVIA has over 10,000 customers including big pharma. I was concerned IQVIA was going to struggle following the pandemic, but they have continued to deliver strong financial marks and seem to expect significant growth in the coming years.
IQVIA is one of my favorite investments thanks to it being one of the leading CROs with a broad array of services. IQVIA has over 10,000 customers including big pharma. I was concerned IQVIA was going to struggle following the pandemic, but they have continued to deliver strong financial marks and seem to expect significant growth in the coming years.
PRNewsWire
25 Tage alt
|
Neutral
Lasso announces a significant step forward in healthcare marketing measurement
The healthcare marketing and analytics leader expands their Measurement Suite to include unprecedented audience and campaign insights. AUSTIN, Texas , Jan. 3, 2023 /PRNewswire/ -- Lasso, an IQVIA (IQV) business and provider of a leading healthcare marketing and analytics operating system, announced the integration of IQVIA's AIM XR (Audience Identity Manager® XR) into their operating system, gi...
The healthcare marketing and analytics leader expands their Measurement Suite to include unprecedented audience and campaign insights. AUSTIN, Texas , Jan. 3, 2023 /PRNewswire/ -- Lasso, an IQVIA (IQV) business and provider of a leading healthcare marketing and analytics operating system, announced the integration of IQVIA's AIM XR (Audience Identity Manager® XR) into their operating system, gi...
Firmenprofil
Bietet biopharmazeutische Entwicklungsdienste und kommerzielle Outsourcing-Dienstleistungen
| Hauptsitz | USA |
| CEO | Ari Bousbib |
| Mitarbeiter | 79.000 |
| Gegründet | 1982 |
| Webseite | www.iqvia.com |
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
